Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule
Shiho Suzuki(Dokkyo University), Koichi Hirata(Japan Coal Energy Center), Mukuto Shioda(Dokkyo Medical University), Keisuke Suzuki(NEC (Japan)), Tomohiko Shiina(Dokkyo Medical University), Keisuke Suzuki(Dokkyo Medical University), Saro Kobayashi(Dokkyo Medical University)
Cited by 2
Related Papers
Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines
|Journal of Hepato-Biliary-Pancreatic Surgery|2007|584
Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines
|Journal of Hepato-Biliary-Pancreatic Surgery|2007|489
The role of gut hormones and the hypothalamus in appetite regulation
|Endocrine Journal|2010|315
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267